Sign inGet started

Williams Glen

Insider CIK 1559209 · GEVA SVP, Technical Operations

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GEVA SYNAGEVA BIOPHARMA CORP D To issuer deriv2015-06-222015-06-2320,002— $00SEC↗
GEVA SYNAGEVA BIOPHARMA CORP D To issuer deriv2015-06-222015-06-2333,750— $00SEC↗
GEVA SYNAGEVA BIOPHARMA CORP D To issuer deriv2015-06-222015-06-2313,334— $00SEC↗
GEVA SYNAGEVA BIOPHARMA CORP D To issuer2015-06-222015-06-2325,500— $00SEC↗
GEVA SYNAGEVA BIOPHARMA CORP A Award2015-06-222015-06-2356$78.87 $4.4K26,024SEC↗
GEVA SYNAGEVA BIOPHARMA CORP D To issuer2015-06-222015-06-23524— $025,500SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise deriv2015-06-082015-06-09833— $020,002SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise deriv2015-06-082015-06-0911,250— $033,750SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise deriv2015-06-082015-06-09833— $013,334SEC↗
GEVA SYNAGEVA BIOPHARMA CORP S Sale2015-06-082015-06-092,520$215.72 $543.6K25,968SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise2015-06-082015-06-09833$57.56 $47.9K27,634SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise2015-06-082015-06-0911,250$80.35 $903.9K38,884SEC↗
GEVA SYNAGEVA BIOPHARMA CORP S Sale2015-06-082015-06-0910,396$214.72 $2.23M28,488SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise2015-06-082015-06-09833$40.32 $33.6K26,801SEC↗
GEVA SYNAGEVA BIOPHARMA CORP A Award2015-06-052015-06-0925,500— $025,968SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise deriv2015-05-062015-05-08833— $014,167SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise deriv2015-05-062015-05-08833— $020,835SEC↗
GEVA SYNAGEVA BIOPHARMA CORP S Sale2015-05-062015-05-08400$204.94 $82.0K1,068SEC↗
GEVA SYNAGEVA BIOPHARMA CORP S Sale2015-05-062015-05-08666$203.99 $135.9K1,468SEC↗
GEVA SYNAGEVA BIOPHARMA CORP S Sale2015-05-062015-05-08400$206.27 $82.5K668SEC↗
GEVA SYNAGEVA BIOPHARMA CORP S Sale2015-05-062015-05-08100$206.97 $20.7K568SEC↗
GEVA SYNAGEVA BIOPHARMA CORP S Sale2015-05-062015-05-08100$215.26 $21.5K468SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise2015-05-062015-05-08833$40.32 $33.6K1,301SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise2015-05-062015-05-08833$57.56 $47.9K2,134SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise deriv2015-04-082015-04-0915,263— $021,668SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise deriv2015-04-082015-04-0924,600— $015,000SEC↗
GEVA SYNAGEVA BIOPHARMA CORP S Sale2015-04-082015-04-0939,863$96.08 $3.83M468SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise2015-04-082015-04-0924,600$57.56 $1.42M40,331SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise2015-04-082015-04-0915,263$40.32 $615.4K15,731SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise deriv2015-04-072015-04-092,769— $036,931SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise2015-04-072015-04-092,769$40.32 $111.6K3,237SEC↗
GEVA SYNAGEVA BIOPHARMA CORP A Award2015-04-072015-04-0985$76.88 $6.5K468SEC↗
GEVA SYNAGEVA BIOPHARMA CORP S Sale2015-04-072015-04-092,769$96.04 $265.9K468SEC↗
GEVA SYNAGEVA BIOPHARMA CORP A Award2014-06-302014-07-02117$54.89 $6.4K383SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise deriv2014-06-252014-06-26300— $039,700SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise deriv2014-06-252014-06-26400— $039,600SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise2014-06-252014-06-26400$57.56 $23.0K966SEC↗
GEVA SYNAGEVA BIOPHARMA CORP M Exercise2014-06-252014-06-26300$40.32 $12.1K566SEC↗
GEVA SYNAGEVA BIOPHARMA CORP S Sale2014-06-252014-06-26700$108.02 $75.6K266SEC↗
GEVA SYNAGEVA BIOPHARMA CORP A Award deriv2014-06-042014-06-0545,000— $045,000SEC↗
GEVA SYNAGEVA BIOPHARMA CORP A Award2013-12-312014-01-02132$36.30 $4.8K266SEC↗
GEVA SYNAGEVA BIOPHARMA CORP A Award2013-06-282013-07-01134$35.68 $4.8K134SEC↗
GEVA SYNAGEVA BIOPHARMA CORP A Award deriv2013-06-062013-06-1040,000— $040,000SEC↗
GEVA SYNAGEVA BIOPHARMA CORP A Award deriv2012-10-042012-10-0940,000— $040,000SEC↗